187 related articles for article (PubMed ID: 14504928)
1. Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells.
Toan SV; To KK; Leung GP; de Souza MO; Ward JL; Tse CM
Pflugers Arch; 2003 Nov; 447(2):195-204. PubMed ID: 14504928
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Ritzel RG; Mowles DA; Carpenter P; Chen XZ; Karpinski E; Hyde RJ; Baldwin SA; Cass CE; Young JD
J Biol Chem; 2001 Jan; 276(4):2914-27. PubMed ID: 11032837
[TBL] [Abstract][Full Text] [Related]
3. Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3.
Smith KM; Slugoski MD; Cass CE; Baldwin SA; Karpinski E; Young JD
Mol Membr Biol; 2007; 24(1):53-64. PubMed ID: 17453413
[TBL] [Abstract][Full Text] [Related]
4. Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib).
Ritzel MW; Ng AM; Yao SY; Graham K; Loewen SK; Smith KM; Hyde RJ; Karpinski E; Cass CE; Baldwin SA; Young JD
Mol Membr Biol; 2001; 18(1):65-72. PubMed ID: 11396613
[TBL] [Abstract][Full Text] [Related]
5. The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics.
Smith KM; Slugoski MD; Loewen SK; Ng AM; Yao SY; Chen XZ; Karpinski E; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2005 Jul; 280(27):25436-49. PubMed ID: 15870078
[TBL] [Abstract][Full Text] [Related]
6. Interaction of benzopyranone derivatives and related compounds with human concentrative nucleoside transporters 1, 2 and 3 heterologously expressed in porcine PK15 nucleoside transporter deficient cells. Structure-activity relationships and determinants of transporter affinity and selectivity.
Wang C; Pimple S; Buolamwini JK
Biochem Pharmacol; 2010 Feb; 79(3):307-20. PubMed ID: 19735647
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
8. HPLC reveals novel features of nucleoside and nucleobase homeostasis, nucleoside metabolism and nucleoside transport.
Altaweraqi RA; Yao SYM; Smith KM; Cass CE; Young JD
Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183247. PubMed ID: 32126230
[TBL] [Abstract][Full Text] [Related]
9. Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na(+) nucleoside cotransporters hCNT1 and hCNT2.
Loewen SK; Ng AM; Yao SY; Cass CE; Baldwin SA; Young JD
J Biol Chem; 1999 Aug; 274(35):24475-84. PubMed ID: 10455109
[TBL] [Abstract][Full Text] [Related]
10. Substituted cysteine accessibility method (SCAM) analysis of the transport domain of human concentrative nucleoside transporter 3 (hCNT3) and other family members reveals features of structural and functional importance.
Mulinta R; Yao SYM; Ng AML; Cass CE; Young JD
J Biol Chem; 2017 Jun; 292(23):9505-9522. PubMed ID: 28385889
[TBL] [Abstract][Full Text] [Related]
11. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
Damaraju VL; Smith KM; Mowles D; Nowak I; Karpinski E; Young JD; Robins MJ; Cass CE
Biochem Pharmacol; 2011 Jan; 81(1):82-90. PubMed ID: 20854794
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene.
Damaraju S; Zhang J; Visser F; Tackaberry T; Dufour J; Smith KM; Slugoski M; Ritzel MW; Baldwin SA; Young JD; Cass CE
Pharmacogenet Genomics; 2005 Mar; 15(3):173-82. PubMed ID: 15861042
[TBL] [Abstract][Full Text] [Related]
13. A conformationally mobile cysteine residue (Cys-561) modulates Na+ and H+ activation of human CNT3.
Slugoski MD; Smith KM; Mulinta R; Ng AM; Yao SY; Morrison EL; Lee QO; Zhang J; Karpinski E; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2008 Sep; 283(36):24922-34. PubMed ID: 18621735
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine.
Ritzel MW; Yao SY; Ng AM; Mackey JR; Cass CE; Young JD
Mol Membr Biol; 1998; 15(4):203-11. PubMed ID: 10087507
[TBL] [Abstract][Full Text] [Related]
15. SLC28 genes and concentrative nucleoside transporter (CNT) proteins.
Pastor-Anglada M; Cano-Soldado P; Errasti-Murugarren E; Casado FJ
Xenobiotica; 2008 Jul; 38(7-8):972-94. PubMed ID: 18668436
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
Gupte A; Buolamwini JK
Bioorg Med Chem Lett; 2009 Feb; 19(3):917-21. PubMed ID: 19097778
[TBL] [Abstract][Full Text] [Related]
17. Substituted cysteine accessibility method analysis of human concentrative nucleoside transporter hCNT3 reveals a novel discontinuous region of functional importance within the CNT family motif (G/A)XKX3NEFVA(Y/M/F).
Slugoski MD; Ng AML; Yao SYM; Lin CC; Mulinta R; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2009 Jun; 284(25):17281-17292. PubMed ID: 19380585
[TBL] [Abstract][Full Text] [Related]
18. A proton-mediated conformational shift identifies a mobile pore-lining cysteine residue (Cys-561) in human concentrative nucleoside transporter 3.
Slugoski MD; Ng AM; Yao SY; Smith KM; Lin CC; Zhang J; Karpinski E; Cass CE; Baldwin SA; Young JD
J Biol Chem; 2008 Mar; 283(13):8496-507. PubMed ID: 18199742
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity.
Errasti-Murugarren E; Cano-Soldado P; Pastor-Anglada M; Casado FJ
Mol Pharmacol; 2008 Feb; 73(2):379-86. PubMed ID: 17993510
[TBL] [Abstract][Full Text] [Related]
20. Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae.
Zhang J; Visser F; Vickers MF; Lang T; Robins MJ; Nielsen LP; Nowak I; Baldwin SA; Young JD; Cass CE
Mol Pharmacol; 2003 Dec; 64(6):1512-20. PubMed ID: 14645682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
